CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 62 filers reported holding CITIUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $9,106 | +18.6% | 10,148 | 0.0% | 0.00% | – |
| Q4 2023 | $7,677 | +10.5% | 10,148 | 0.0% | 0.00% | – |
| Q3 2023 | $6,945 | -43.0% | 10,148 | 0.0% | 0.00% | – |
| Q2 2023 | $12,178 | -23.9% | 10,148 | +14.0% | 0.00% | -100.0% |
| Q1 2022 | $16,000 | +14.3% | 8,903 | 0.0% | 0.00% | – |
| Q4 2021 | $14,000 | -22.2% | 8,903 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $18,000 | -41.9% | 8,903 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $31,000 | – | 8,903 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 198,632 | $232,399 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 452,561 | $529 | 0.05% |
| Wealth Advisory Solutions, LLC | 155,850 | $182,345 | 0.05% |
| CHELSEA COUNSEL CO | 81,300 | $95,121 | 0.05% |
| Horst & Graben Wealth Management LLC | 75,722 | $89,000 | 0.02% |
| Miller Investment Management, LP | 50,000 | $58,500 | 0.01% |
| Pasadena Private Wealth, LLC | 10,965 | $12,829 | 0.00% |
| Jump Financial, LLC | 66,143 | $77,387 | 0.00% |
| Lighthouse Investment Partners, LLC | 36,126 | $42,267 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 75,188 | $87,970 | 0.00% |